The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Predictors of financial burden at a comprehensive cancer center.
 
Sheetal Mehta Kircher
No Relationships to Disclose
 
Joshua P Rutsohn
No Relationships to Disclose
 
Jessica Lee Yarber
No Relationships to Disclose
 
Yanina Guevara
No Relationships to Disclose
 
Madison M Lyleroehr
No Relationships to Disclose
 
Halla Sayed Nimeiri
No Relationships to Disclose
 
Jyoti D. Patel
Research Funding - Novartis (Inst)
 
Mark Agulnik
No Relationships to Disclose
 
Mary Frances Mulcahy
No Relationships to Disclose
 
Al Bowen Benson
Consulting or Advisory Role - Alchemia; Astellas Pharma; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; EMD Serono; Genentech/Roche; Genomic Health; Infinity Pharmaceuticals; Lilly/ImClone; Merck Serono; Merck/Schering Plough; National Cancer Institute; Pharmacyclics; Precision Therapeutics; Sanofi; Spectrum Pharmaceuticals; Taiho Pharmaceutical; Vicus Therapeutics
Research Funding - advanced accelerator applications; Alchemia; Amgen; Astellas Pharma; AVEO; Bayer/Onyx; EMD Serono (Inst); Genentech (I); Gilead Sciences; Infinity Pharmaceuticals; Merck Serono (Inst); Novartis
Travel, Accommodations, Expenses - Astellas Pharma; AVEO; Bayer; Genentech/Roche; Gilead Sciences; Lilly/ImClone; Sanofi; Spectrum Pharmaceuticals
 
Jonas A. De Souza
Speakers' Bureau - AstraZeneca
 
Sofia M Garcia
No Relationships to Disclose